ZC38 (Hydroxychloroquine 200 mg)
Pill imprint ZC38 has been identified as Hydroxychloroquine sulfate 200 mg.
Hydroxychloroquine is used in the treatment of systemic lupus erythematosus; rheumatoid arthritis; sjogren's syndrome; undifferentiated connective tissue disease; lyme disease, arthritis (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).
- 200 mg
- 13.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Zydus Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- calcium phosphate dihydrate dibasic
pregelatinized corn starch
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|68084-0269||Amerisource Health Services|
|63739-0777||McKesson Packaging Services|
More about hydroxychloroquine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 162 Reviews – Add your own review/rating
- Drug class: antimalarial quinolines
Other brands: Plaquenil
- Hydroxychloroquine Sulfate (AHFS Monograph)
- Hydroxychloroquine Tablets (FDA)
- Hydroxychloroquine (Wolters Kluwer)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.